Financial Times FT.com

Allergan sweet spot for GSK as rumors abound of a possible bid

By Sasha Damouni and Nadia Damouni

Published: March 24 2009 17:22 | Last updated: March 24 2009 17:22

Email options

The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.Terms of use |Privacy policy

* required fields



(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)